8 Things to know before SHELTER PHARMA IPO

ipo for shelter pharma logo

key highlights for IPO:


Established in 2007, Shelter Pharma Limited, formerly recognized as Shelter Pharmacy, operates within the realm of manufacturing herbal products, encompassing both the Human Pharma and Veterinary sectors. As part of its growth strategy, the company is currently considering an initial public offering (IPO) to expand its reach and strengthen its position in the market. The company has gained a solid reputation for producing high-quality pharmaceutical products, ensuring the well-being of both humans and animals.

Based in Himmatnagar, Gujarat, the company is a bastion of producing herbal medicines that cater to the realms of veterinary, poultry, and human healthcare. The core philosophy driving the company is to provide cost-effective and superior solutions to the health challenges faced by both humans and animals.

Within its repertoire, Shelter Pharma Limited presents an expansive array of health supplements tailored to enhance human and poultry well-being. The company prides itself on harmonizing the principles of Ayurveda with modernity, a fusion that propels its endeavors.

Shelter Pharma’s offerings encompass a spectrum of products catering to both Human Healthcare and Veterinary Healthcare domains. Among the Human Healthcare roster, products such as Lemonade Barley Water, Sherolax, Baldeepak, and Stonyl Tablets stand out. For the Veterinary Healthcare sector, products like Agrical Powder, Lactocal Gel, and Shelodex Ultra Ointment are featured.

Notably, Shelter Pharma’s clientele primarily hails from rural and semi-urban markets, underscoring the company’s reach into communities where its products have a significant impact

Shelter Pharma IPO Details

  • Shelter Pharma IPO operates as a Fixed Price Issue.
  • The total issue size of the IPO amounts to Rs 16.03 Crores.
  • Shelter Pharma IPO is priced at ₹42 per share.
  • The IPO is set to be listed on BSE SME.

IPO Date
Aug 10, 2023 to Aug 14, 2023
Listing DateWednesday, 23 August 2023
Price₹42 per share
Lot Size3000 Shares
Total Issue Size
Aug 10, 2023, to Aug 14, 2023
Fresh Issue
(aggregating up to ₹16.03 Cr)
Market Maker portion
Gretex Share Broking

Shelter Pharma IPO Timetable (Tentative)

Shelter Pharma IPO opens on Aug 10, 2023, and closes on Aug 14, 2023.

IPO Open Date
Thursday, 10 August 2023
IPO Close Date
Monday, 14 August 2023
Basis of Allotment
Friday, 18 August 2023
Initiation of Refunds
Monday, 21 August 2023
Credit of Shares to Demat
Tuesday, 22 August 2023
Listing Date
Wednesday, 23 August 2023
Cut-off time for UPI mandate confirmation
5 PM on Aug 14, 2023
ipo products of shelter pharma

Key Performance Indicator

P/E (x)5.62
EPS (Rs)7.47

Shelter Pharma IPO Reservation

  • Shelter Pharma IPO offers a total of 3,624,000 shares.
  • Retail Individual Investors (RII) category is allocated 1,812,000 shares, representing 50.00% of the total.
  • Non-Institutional Investors (NII) category is allocated 1,810,000 shares, accounting for 49.94% of the total.
Anchor Investor Shares Offered
Market Maker Shares Offered194,000 (5.35%)
Other Shares Offered1,810,000 (49.94%)
Retail Shares Offered1,812,000 (50.00%)
Total Shares Offered3,624,000 (100%)

Company Financials

Shelter Pharma IPO Financial Information (Restated)

Period Ended31 Mar 202131 Mar 202231 Mar 2023
Profit After Tax-23.88183.70578.33
Net Worth711.17880.421,451.06
Reserves and Surplus 667.40844.45676.68
Total Borrowing0.4613.12178.41

Objects of the Issue

The company intends to utilize the net fresh issue proceeds for the following objects:

a) Working capital requirements and

b) General corporate purposes.

Shelter Pharma IPO Review (I would Avoid)

  • The company operates within the realm of manufacturing and marketing herbal products.
  • However, the remarkable profits displayed for FY23 have raised suspicions, suggesting possible financial manipulation.
  • The requested price, based on these extraordinary earnings, presents an enticing 8.4 P/E ratio.
  • Nevertheless, concerns arise about the sustainability of such performance in the long term.
  • Despite the initial allure of the valuation, it might be wise to consider skipping this offering due to the uncertainties surrounding it.

Shelter Pharma IPO Subscription Status (Bidding Detail)

As of August 11, 2023, at 7:02 PM, the Shelter Pharma IPO has garnered a subscription rate of:

  • Overall Subscription: 3.21 times
  • Retail Category Subscription: 5.62 times
  • QIB (Qualified Institutional Buyers) Category Subscription: Yet to be specified
  • NII (Non-Institutional Investors) Category Subscription: 0.45 times

For the latest and detailed subscription information, including Day by Day Subscription Details, please refer to the live status updates.

GMP(grey market premium)

  • Shelter Pharma’s latest IPO GMP today stands at approximately ₹5(+/-) as of the latest update on August 12th, 2023, at 10:22 PM.
  • Given the price band of ₹42.00, the estimated listing price for the Shelter Pharma SME IPO is around ₹47 (cap price + today’s GMP).
  • This suggests an expected gain/loss per share of approximately 11.90% in terms of percentage.
  • The Shelter Pharma SME IPO Retail Subject to Sauda is at ₹11,400, reflecting the dynamics of retail participation in the market.


The content provided here should not be interpreted as an invitation or solicitation to buy or sell securities, nor should it be regarded as guidance for such actions. All material presented is intended solely for educational and informational purposes and should not be utilized for making investment choices in any manner. It is imperative to recognize that any data shared here carries no intent to influence investment decisions. Any individual considering investment moves should first seek guidance from a qualified financial advisor, taking into account the particulars of their circumstances.

It is vital to underscore that any decisions based on the information shared here are undertaken at one’s own risk. As with all investments in the stock market, it’s important to acknowledge the inherent and unpredictable risks associated with such endeavors.

Leave a Reply

Your email address will not be published. Required fields are marked *